| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053912A1 α-(N-SULPHONAMIDO)ACETAMIDE DERIVATIVES AS β-AMYLOID INHIBITORS |
| 07/03/2003 | WO2003053522A1 Methods of treating bacterial infections in dogs and cats |
| 07/03/2003 | WO2003053474A2 Use of micro-organisms for a directed delivery of substances to specific parts of the gut |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053466A1 Skin barrier function repair accelerators |
| 07/03/2003 | WO2003053457A1 Polypeptide, the conjugate thereof containing doxorubicine and a pharmaceutical composition based thereon |
| 07/03/2003 | WO2003053456A1 Use of hyperforin or st john's wort extracts against anaphylactic states of shock and for maintaining and improving bone health |
| 07/03/2003 | WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 07/03/2003 | WO2003053443A1 Substituted diketopiperazines as oxytocin antagonists |
| 07/03/2003 | WO2003053442A1 Tempamine compositions and methods of use |
| 07/03/2003 | WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 07/03/2003 | WO2003053440A1 Medicinal composition |
| 07/03/2003 | WO2003053436A1 Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
| 07/03/2003 | WO2003053435A1 Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors |
| 07/03/2003 | WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | WO2003053433A1 Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
| 07/03/2003 | WO2003053432A1 5ht4 partial agonist pharmaceutical compositions |
| 07/03/2003 | WO2003053431A2 Pharmaceutical compositions based on azetidine derivatives |
| 07/03/2003 | WO2003053424A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 07/03/2003 | WO2003053409A1 Liposome composition for delivery of nucleic acid |
| 07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053365A2 Syn3 compositions and methods |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 07/03/2003 | WO2003053360A2 Treatment of ebv and khsv infection and associated abnormal cellular proliferation |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053353A2 Administration of vasopeptidase inhibitors to reduce pulse pressure |
| 07/03/2003 | WO2003053331A2 Protease inhibitors |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2003053325A2 Microencapsulation of drugs by solvent exchange |
| 07/03/2003 | WO2003053224A2 Novel compositions and methods for cancer |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | WO2003053169A1 Soft drink replacer |
| 07/03/2003 | WO2003053166A1 Food or pet food composition containing plant extract for bone health |
| 07/03/2003 | WO2003053165A1 Matrix-forming composition containing pectin |
| 07/03/2003 | WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders |
| 07/03/2003 | WO2003018788A3 Improved nitroreductase enzymes |
| 07/03/2003 | WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/03/2003 | WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles |
| 07/03/2003 | WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002036761A3 Compositions and methods for the diagnosis of cancer |
| 07/03/2003 | WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 07/03/2003 | WO2002018389A3 Thienopyrimidine |
| 07/03/2003 | US20030125569 Use of packing strip as a holographic data carrier |
| 07/03/2003 | US20030125559 Methods for synthesizing ether compounds and intermediates therefor |
| 07/03/2003 | US20030125557 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | US20030125537 Neovascularization; platelet derived growth factors; vascular permeability factors; wound healing agents; antitumor/antiproliferative agents; antisense agents; for treatment of intestinal malabsorption syndrome |
| 07/03/2003 | US20030125533 Regulation of human sphingosine kinase-like protein |
| 07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
| 07/03/2003 | US20030125519 Ligand for the c-kit receptor and methods of use thereof |
| 07/03/2003 | US20030125391 Pharmaceutical solutions of modafinil compounds |
| 07/03/2003 | US20030125383 For treating or preventing emphysema, cancer and dermatological disorders |
| 07/03/2003 | US20030125378 Skin treatment, cosmetics |
| 07/03/2003 | US20030125377 Aromatase inhibitors from Broussonetia papyrifera |
| 07/03/2003 | US20030125376 Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| 07/03/2003 | US20030125375 Eurotinones, and derivatives thereof, processes for preparing them, and their use |
| 07/03/2003 | US20030125371 Substituted indole acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |
| 07/03/2003 | US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis |
| 07/03/2003 | US20030125356 Reacting a methylketophenolic compound with a benzaldehyde compound to produce an intermediate, cyclizing the intermediate in presence of a base; anticarcinogenic agent, and treats diseases induced by cell proliferation |
| 07/03/2003 | US20030125351 Administering a heterocyclic amide compound to a glaucoma patient for inhibiting contraction of ciliary muscle; Rho kinase inhibitor |
| 07/03/2003 | US20030125350 Combination of formoterol and a tiotropium salt |
| 07/03/2003 | US20030125346 Amino-substituted pyrimidinyl derivatives and methods of use |
| 07/03/2003 | US20030125344 Rho-kinase inhibitors |
| 07/03/2003 | US20030125343 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/03/2003 | US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents |
| 07/03/2003 | US20030125339 Substituted alkylamine derivatives and methods of use |
| 07/03/2003 | US20030125335 Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia |
| 07/03/2003 | US20030125334 5-HT receptor ligands and uses thereof |
| 07/03/2003 | US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease |
| 07/03/2003 | US20030125330 Anxiolytics and antidepressants |
| 07/03/2003 | US20030125327 Prodrugs of imidazopyridine derivatives |
| 07/03/2003 | US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents |
| 07/03/2003 | US20030125320 Seratonin reuptake inhibitors potently binding to the 5-HT1A receptor, dopaminergic agents; antidepressants, psychosis, anxiolytic and antiischemic agents; panic order; obsessive compulsive disorder, impulse control disorder, alcohol abuse |
| 07/03/2003 | US20030125319 Administering an estrogen agonist/ antagonist while reducing the side effects associated with estrogen administration; urinary and vaginal infections; incontinence; vaginal dryness; kits for assessing vaginal health |
| 07/03/2003 | US20030125309 Cyclic ether vitamin D3 compounds, 1alpha(OH) 3-epi- vitamin D3 compounds and uses thereof |
| 07/03/2003 | US20030125305 Treating patients who have become resistant to a Brc-Abl tyrosine kinase inhibitor, e.g., imatinib mesylate, with a nucleoside analog of a 2-cytosinyl-1,3-dioxolane; chronic myelogenous leukemia in blastic phase; anticarcinogenic agents |
| 07/03/2003 | US20030125290 Cancer treatment with a synthetic sequences |
| 07/03/2003 | US20030125282 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER) |
| 07/03/2003 | US20030125266 Administering a 14 membered macrolide and ketolide antibiotics containing C12 modifications to a patient suffering from bacterial infections |
| 07/03/2003 | US20030125262 Methods and reagents for regulation of cellular responses in biological systems |
| 07/03/2003 | US20030125259 Administering to the mammal a therapeutically acceptable amount of a octa or nonapeptide compound to inhibit the angiogenesis |
| 07/03/2003 | US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin |
| 07/03/2003 | US20030125252 Administering to a vertebrate an effective osteogenesis stimulating amount of an RAR (retinoic acid receptor) antagonist to treat both metabolic or non-metabolic diseases; RAR antisense oligonucleotide |
| 07/03/2003 | US20030125248 Novel bone mineralization proteins, DNA, vectors expression systems |
| 07/03/2003 | US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 07/03/2003 | US20030125236 Phospholipids, bioactive agent and excipients and the pulmonary delivery thereof. Dry powder inhaled insulin formulations are disclosed. Improved formulations comprising DPPC, insulin and sodium citrate which are useful in the |
| 07/03/2003 | US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment |
| 07/03/2003 | US20030124723 Use of a nuclease inhibitor or interleukin-10 (IL-10) for the preparation of a therapeutic composition for improving transfection of a polynucleotide into a cell and compositions useful in gene therapy |
| 07/03/2003 | US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 07/03/2003 | US20030124602 Tumour suppresor and uses thereof |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124591 Gene used in diagnosis and treatment |
| 07/03/2003 | US20030124582 Polypeptide encoded by a polynucleotide of given sequence; detecting the effect of a test compound on the production of mRNA; use in identifying agonists/antagonists that may be useful in therapy |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |